Description
Letrozol CRCA Coated Tablets 2.5 mg.
Letrozol CRCA coated tablets are a medication used to treat certain types of breast cancer in women after menopause. Each tablet contains 2.5 mg. of letrozole, which is the active ingredient in this medication. Letrozole belongs to a class of drugs known as aromatase inhibitors, which work by decreasing the amount of estrogen produced in the body. This can help slow or stop the growth of certain types of breast tumors that require estrogen to grow.
Indications
Letrozol CRCA coated tablets are indicated for the treatment of postmenopausal women with hormone receptor-positive early breast cancer or advanced breast cancer. It may be used as adjuvant therapy (treatment given after the primary treatment) in early breast cancer or as first-line treatment in advanced breast cancer.
Dosage and Administration
The usual dose of Letrozol CRCA coated tablets is 2.5 mg. taken once daily, with or without food. It is important to take the medication at the same time each day to maintain a consistent level in the body. The duration of treatment will be determined by your healthcare provider based on your individual condition and response to the medication.
Contraindications
Letrozol CRCA coated tablets are contraindicated in women who are pregnant or breastfeeding, as the medication can cause harm to the unborn baby or nursing infant. It should also not be used in premenopausal women or women with a known hypersensitivity to letrozole or any other ingredients in the tablets.
Side Effects
Common side effects of Letrozol CRCA coated tablets may include hot flashes, fatigue, joint pain, headache, and increased sweating. These side effects are usually mild and may improve as your body adjusts to the medication. However, if you experience any severe or persistent side effects, it is important to contact your healthcare provider.
Precautions
Before taking Letrozol CRCA coated tablets, inform your healthcare provider about any medical conditions you have, especially liver disease or osteoporosis. Letrozole may cause bone loss, so your doctor may recommend bone density testing and prescribe additional treatments to help protect your bones.
Drug Interactions
Letrozol CRCA coated tablets may interact with certain medications, including tamoxifen, estrogen-containing therapies, and some selective serotonin reuptake inhibitors (SSRIs). It is important to inform your healthcare provider of all medications you are taking, including prescription, over-the-counter, and herbal supplements, to avoid potential drug interactions.
Storage
Store Letrozol CRCA coated tablets at room temperature away from moisture and heat. Keep the medication in its original packaging and out of reach of children and pets. Do not use the tablets if the packaging is damaged or if the expiration date has passed.
Conclusion
Letrozol CRCA coated tablets are an important medication used in the treatment of certain types of breast cancer in postmenopausal women. By inhibiting estrogen production in the body, letrozole can help slow or stop the growth of hormone receptor-positive breast tumors. It is essential to follow your healthcare provider’s instructions for taking this medication and to report any side effects or concerns during treatment. If you have any questions about Letrozol CRCA coated tablets or your breast cancer treatment plan, do not hesitate to consult your healthcare provider for guidance.
